Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Clinical trial NCT05646316 · RECRUITING

Trial details

NCT number: NCT05646316
Sponsor: NRG Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Start date: 2022-12-07
Primary completion: 2026-10-31
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.